<DOC>
	<DOC>NCT00524836</DOC>
	<brief_summary>Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis.</brief_summary>
	<brief_title>Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Male ore female, 16 to 60 years old (inclusive) twoyear history of allergic rhinitis due to house dust mite An ear, nose or throat (ENT) infection asthma requiring daily drug therapy other than ÃŸ2 inhaled agonists taken prn atopic dermatitis or urticaria requiring an antihistamine or corticosteroid treatment an associated ENT disease use of decongestants nasal or ocular topical treatment desensitivation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>levocetirizine dihydrochloride</keyword>
	<keyword>Xyzal tablets</keyword>
</DOC>